HIGHLIGHTS
- who: Simona Camorani from the Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Via Pansini, Naples, Italy have published the paper: Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer, in the Journal: (JOURNAL)
- what: The authors recently proved that tumor growth and lung are impaired in mouse models of human TNBC by a high efficacious PDGFRβ Hence the authors aimed at investigating the effectiveness of a novel combination treatment with the PDGFRβ and anti-PD-L1 mAbs in TNBC. The authors show that the PDGFRβ the anti . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.